{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:04:11Z","timestamp":1792458251581,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019741","name":"Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09150162410064"],"award-info":[{"award-number":["09150162410064"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["09150182010020"],"award-info":[{"award-number":["09150182010020"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101141346"],"award-info":[{"award-number":["101141346"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["01-001-2024-0601"],"award-info":[{"award-number":["01-001-2024-0601"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Associations between the gut microbiota and cardiometabolic health are well established, but evidence from longitudinal studies remains limited. In the prospective multi-ethnic HELIUS cohort, we investigated whether baseline gut microbiota composition was associated with long-term cardiometabolic outcomes. Fecal samples from 4792 participants were collected at baseline and analyzed using 16S rRNA sequencing. At follow-up, new diagnoses of hypertension, dyslipidemia, and diabetes were assessed, and major adverse cardiovascular events (MACE and MACE\u2009+\u2009, including angina pectoris) were obtained from hospital and mortality registries. Logistic regression was used to study associations with incident cardiometabolic disease, while Cox regression evaluated associations with MACE among participants without cardiovascular disease at baseline. During follow-up, 129 participants experienced MACE (2.7%) and 180 MACE+ (3.8%). Higher abundance of\n                    <jats:italic>Eubacterium xylanophilum<\/jats:italic>\n                    group spp. and\n                    <jats:italic>Akkermansia muciniphila<\/jats:italic>\n                    was associated with lower MACE+ risk, whereas\n                    <jats:italic>Ruminococcus gnavus<\/jats:italic>\n                    group spp. was associated with higher MACE risk, although only\n                    <jats:italic>Eubacterium xylanophilum<\/jats:italic>\n                    group spp. remained significant after full adjustment. Several taxa were associated with incident cardiometabolic disease, and exploratory metabolomics linked\n                    <jats:italic>Ruminococcus gnavus<\/jats:italic>\n                    group spp. to bile acid and acylcarnitine metabolites. These findings suggest that gut microbiota composition is longitudinally associated with cardiometabolic disease.\n                  <\/jats:p>","DOI":"10.1038\/s41522-026-00952-6","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:24:26Z","timestamp":1772861066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Specific gut microbes are associated with the incidence of cardiometabolic disease in the HELIUS cohort"],"prefix":"10.1038","volume":"12","author":[{"given":"Barbara J. H.","family":"Verhaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Bouwmeester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Galenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert-Jan H.","family":"van den Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Nieuwdorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"key":"952_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","volume":"127","author":"M Witkowski","year":"2020","unstructured":"Witkowski, M., Weeks, T. L. & Hazen, S. L. Gut microbiota and cardiovascular disease. Circ. Res. 127, 553\u2013570 (2020).","journal-title":"Circ. Res."},{"key":"952_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","volume":"26","author":"RS Kootte","year":"2017","unstructured":"Kootte, R. S. et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 26, 611\u2013619.e6 (2017).","journal-title":"Cell Metab."},{"key":"952_CR3","doi-asserted-by":"crossref","unstructured":"Verhaar, B. J. H. et al. Effects of oral butyrate on blood pressure in patients with hypertension: a randomized, placebo-controlled trial. Hypertension 81, 2124\u20132136 (2024).","DOI":"10.1161\/HYPERTENSIONAHA.123.22437"},{"key":"952_CR4","doi-asserted-by":"crossref","unstructured":"Jama, H. A. et al. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial. Nat. Cardiovasc. Res. 2, 35\u201343 (2023).","DOI":"10.1038\/s44161-022-00197-4"},{"key":"952_CR5","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-018-0160-1","volume":"24","author":"M Deschasaux","year":"2018","unstructured":"Deschasaux, M. et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat. Med. 24, 1526\u20131531 (2018).","journal-title":"Nat. Med."},{"key":"952_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa704","author":"BJH Verhaar","year":"2020","unstructured":"Verhaar, B. J. H. et al. Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study. Eur. Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa704 (2020).","journal-title":"Eur. Heart J."},{"key":"952_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01295-7","volume":"16","author":"M Balvers","year":"2024","unstructured":"Balvers, M. et al. Ethnic variations in metabolic syndrome components and their associations with the gut microbiota: the HELIUS study. Genome Med. 16, 41 (2024).","journal-title":"Genome Med."},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.chom.2022.08.013","volume":"30","author":"U Boulund","year":"2022","unstructured":"Boulund, U. et al. Gut microbiome associations with host genotype vary across ethnicities and potentially influence cardiometabolic traits. Cell Host Microbe 30, 1464\u20131480. e6 (2022).","journal-title":"Cell Host Microbe"},{"key":"952_CR9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1111\/j.1462-2920.2009.01900.x","volume":"11","author":"M Rajili\u0107-Stojanovi\u0107","year":"2009","unstructured":"Rajili\u0107-Stojanovi\u0107, M. et al. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 11, 1736\u20131751 (2009).","journal-title":"Environ. Microbiol."},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nature11319","volume":"488","author":"MJ Claesson","year":"2012","unstructured":"Claesson, M. J. et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178\u2013184 (2012).","journal-title":"Nature"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/CIRCRESAHA.115.306807","volume":"117","author":"J Fu","year":"2015","unstructured":"Fu, J. et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ. Res. 117, 817\u2013824 (2015).","journal-title":"Circ. Res."},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/foods9050645","volume":"9","author":"M Lon\u010dar","year":"2020","unstructured":"Lon\u010dar, M. et al. Coumarins in food and methods of their determination. Foods 9, 645 (2020).","journal-title":"Foods"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/jcm10040715","volume":"10","author":"A Camelo-Castillo","year":"2021","unstructured":"Camelo-Castillo, A. et al. Gut microbiota and the quality of oral anticoagulation in vitamin K antagonists users: a review of potential implications. J. Clin. Med. 10, 715 (2021).","journal-title":"J. Clin. Med."},{"key":"952_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/ATVBAHA.110.215228","volume":"31","author":"K-Y Wang","year":"2011","unstructured":"Wang, K.-Y. et al. Histamine deficiency decreases atherosclerosis and inflammatory response in apolipoprotein E knockout mice independently of serum cholesterol level. Arterioscler Thromb. Vasc. Biol. 31, 800\u2013807 (2011).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/ATVBAHA.109.201079","volume":"30","author":"I Rozenberg","year":"2010","unstructured":"Rozenberg, I. et al. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arterioscler Thromb. Vasc. Biol. 30, 923\u2013930 (2010).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"952_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0021-9150(79)90061-3","volume":"34","author":"GK Owens","year":"1979","unstructured":"Owens, G. K. & Hollis, T. M. Relationship between inhibition of aortic histamine formation, aortic albumin permeability and atherosclerosis. Atherosclerosis 34, 365\u2013373 (1979).","journal-title":"Atherosclerosis"},{"key":"952_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m, A., Sayin, S. I., Marschall, H.-U. & B\u00e4ckhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41\u201350 (2016).","journal-title":"Cell Metab."},{"key":"952_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108270","author":"S Miyazaki-Anzai","year":"2014","unstructured":"Miyazaki-Anzai, S., Masuda, M., Levi, M., Keenan, A. L. & Miyazaki, M. Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0108270 (2014).","journal-title":"PLoS ONE"},{"key":"952_CR19","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1210\/jc.2018-01000","volume":"104","author":"M Guasch-Ferr\u00e9","year":"2019","unstructured":"Guasch-Ferr\u00e9, M. et al. Plasma acylcarnitines and risk of type 2 diabetes in a Mediterranean population at high cardiovascular risk. J. Clin. Endocrinol. Metab. 104, 1508\u20131519 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"952_CR20","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3945\/ajcn.116.130492","volume":"103","author":"M Guasch-Ferr\u00e9","year":"2016","unstructured":"Guasch-Ferr\u00e9, M. et al. Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions1, 2, 2. Am. J. Clin. Nutr. 103, 1408\u20131416 (2016).","journal-title":"Am. J. Clin. Nutr."},{"key":"952_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/joim.20090","volume":"297","author":"D Rizo-Roca","year":"2025","unstructured":"Rizo-Roca, D., Henderson, J. D. & Zierath, J. R. Metabolomics in cardiometabolic diseases: key biomarkers and therapeutic implications for insulin resistance and diabetes. J. Intern. Med. 297, 584\u2013607 (2025).","journal-title":"J. Intern. Med."},{"key":"952_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"},{"key":"952_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1631\/jzus.B1700040","volume":"19","author":"Y Zhu","year":"2018","unstructured":"Zhu, Y., Xu, Y., Wang, L. & Qi, B. Biosynthesis of (R)-2-hydroxy-3-phenylpropionic acid using whole recombinant Escherichia coli cells in an aqueous\/n-octane biphasic system. J. Zhejiang Univ. Sci. B 19, 285\u2013292 (2018).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"952_CR24","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1073\/pnas.0812874106","volume":"106","author":"WR Wikoff","year":"2009","unstructured":"Wikoff, W. R. et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106, 3698\u20133703 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"952_CR25","doi-asserted-by":"crossref","unstructured":"Laveriano-Santos, E. P. et al. Enterolignans: from natural origins to cardiometabolic significance, including chemistry, dietary sources, bioavailability, and activity. Crit. Rev. Food Sci. Nutr. 65, 3764\u20133784 (2025).","DOI":"10.1080\/10408398.2024.2371939"},{"key":"952_CR26","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1161\/CIRCRESAHA.123.323634","volume":"134","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Gut microbiota and blood metabolites related to fiber intake and type 2 diabetes. Circ. Res. 134, 842\u2013854 (2024).","journal-title":"Circ. Res."},{"key":"952_CR27","doi-asserted-by":"crossref","unstructured":"Xuan, C. et al. Associations of urinary phytoestrogens with all-cause and cardiovascular mortality in adults: a population-based cohort study. Front. Endocrinol. 15, 1400182 (2024).","DOI":"10.3389\/fendo.2024.1400182"},{"key":"952_CR28","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1080\/19490976.2020.1778261","volume":"11","author":"C Menni","year":"2020","unstructured":"Menni, C. et al. Serum metabolites reflecting gut microbiome alpha diversity predict type 2 diabetes. Gut Microbes 11, 1632\u20131642 (2020).","journal-title":"Gut Microbes"},{"key":"952_CR29","doi-asserted-by":"crossref","unstructured":"Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine 51, 102590 (2020).","DOI":"10.1016\/j.ebiom.2019.11.051"},{"key":"952_CR30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00284-010-9582-9","volume":"61","author":"X Wu","year":"2010","unstructured":"Wu, X. et al. Molecular Characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 61, 69\u201378 (2010).","journal-title":"Curr. Microbiol."},{"key":"952_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.micpath.2017.08.038","volume":"111","author":"M Sedighi","year":"2017","unstructured":"Sedighi, M. et al. Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb. Pathog. 111, 362\u2013369 (2017).","journal-title":"Microb. Pathog."},{"key":"952_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4345","author":"H Wu","year":"2017","unstructured":"Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. https:\/\/doi.org\/10.1038\/nm.4345 (2017).","journal-title":"Nat. Med."},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41586-022-04567-7","volume":"604","author":"R Gacesa","year":"2022","unstructured":"Gacesa, R. et al. Environmental factors shaping the gut microbiome in a Dutch population. Nature 604, 732\u2013739 (2022).","journal-title":"Nature"},{"key":"952_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12109","author":"S Sun","year":"2019","unstructured":"Sun, S. et al. Gut microbiota composition and blood pressure: the CARDIA study. Hypertension https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.118.12109 (2019).","journal-title":"Hypertension"},{"key":"952_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05184-7","volume":"9","author":"MA Jackson","year":"2018","unstructured":"Jackson, M. A. et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat. Commun. 9, 2655 (2018).","journal-title":"Nat. Commun."},{"key":"952_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrcardio.2017.120","volume":"15","author":"FZ Marques","year":"2018","unstructured":"Marques, F. Z., Mackay, C. R. & Kaye, D. M. Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat. Rev. Cardiol. 15, 20\u201332 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"952_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.118.12588","volume":"74","author":"J Huart","year":"2019","unstructured":"Huart, J. et al. Gut microbiota and fecal levels of short-chain fatty acids differ upon 24-hour blood pressure levels in men. Hypertension 74, 1005\u20131013 (2019).","journal-title":"Hypertension"},{"key":"952_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0222-x","author":"J Li","year":"2017","unstructured":"Li, J. et al. Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome https:\/\/doi.org\/10.1186\/s40168-016-0222-x (2017).","journal-title":"Microbiome"},{"key":"952_CR39","doi-asserted-by":"crossref","unstructured":"Yan, Q. et al. Alterations of the gut microbiome in hypertension. Front. Cell. Infect. Microbiol. 7, 381(2017).","DOI":"10.3389\/fcimb.2017.00381"},{"key":"952_CR40","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang, T. et al. Gut dysbiosis is linked to hypertension. Hypertension 65, 1331\u20131340 (2015).","journal-title":"Hypertension"},{"key":"952_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-025-00721-x","volume":"11","author":"L Zeng","year":"2025","unstructured":"Zeng, L. et al. Mediation effect and metabolic pathways of gut microbiota in the associations between lifestyles and dyslipidemia. npj Biofilms Microbiomes 11, 90 (2025).","journal-title":"npj Biofilms Microbiomes"},{"key":"952_CR42","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2337\/dc21-2358","volume":"45","author":"MO Ruuskanen","year":"2022","unstructured":"Ruuskanen, M. O. et al. Gut microbiome composition is predictive of incident type 2 diabetes in a population cohort of 5,572 Finnish adults. Diab. Care 45, 811\u2013818 (2022).","journal-title":"Diab. Care"},{"key":"952_CR43","doi-asserted-by":"publisher","first-page":"13626","DOI":"10.1096\/fj.202001532R","volume":"34","author":"I Robles-Vera","year":"2020","unstructured":"Robles-Vera, I. et al. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension. FASEB J. 34, 13626\u201313640 (2020).","journal-title":"FASEB J."},{"key":"952_CR44","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00331-23","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Probiotics Bifidobacterium lactis M8 and Lactobacillus rhamnosus M9 prevent high blood pressure via modulating the gut microbiota composition and host metabolic products. mSystems 8, e00331\u201323 (2023).","journal-title":"mSystems"},{"key":"952_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-023-00448-7","volume":"9","author":"J Tang","year":"2023","unstructured":"Tang, J. et al. The therapeutic value of bifidobacteria in cardiovascular disease. npj Biofilms Microbiomes 9, 1\u201314 (2023).","journal-title":"npj Biofilms Microbiomes"},{"key":"952_CR46","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s43856-025-00980-x","volume":"5","author":"Y-T Lin","year":"2025","unstructured":"Lin, Y.-T. et al. The association between the gut microbiome and 24-h blood pressure measurements in the SCAPIS study. Commun. Med. 5, 276 (2025).","journal-title":"Commun. Med."},{"key":"952_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2471960","volume":"17","author":"BJH Verhaar","year":"2025","unstructured":"Verhaar, B. J. H. et al. Gut microbiota shift in Ghanaian individuals along the migration axis: the RODAM-Pros cohort. Gut Microbes 17, 2471960 (2025).","journal-title":"Gut Microbes"},{"key":"952_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s43587-020-00014-2","volume":"1","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Sex- and age-related trajectories of the adult human gut microbiota shared across populations of different ethnicities. Nat. Aging 1, 87\u2013100 (2021).","journal-title":"Nat. Aging"},{"key":"952_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-024-00628-z","volume":"10","author":"EMC Vriend","year":"2024","unstructured":"Vriend, E. M. C. et al. Machine learning analysis of sex and menopausal differences in the gut microbiome in the HELIUS study. npj Biofilms Microbiomes 10, 1\u201311 (2024).","journal-title":"npj Biofilms Microbiomes"},{"key":"952_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27187-7","volume":"12","author":"A Gao","year":"2021","unstructured":"Gao, A. et al. Sexual dimorphism in glucose metabolism is shaped by androgen-driven gut microbiome. Nat. Commun. 12, 7080 (2021).","journal-title":"Nat. Commun."},{"key":"952_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0531-y","volume":"15","author":"GE Flores","year":"2014","unstructured":"Flores, G. E. et al. Temporal variability is a personalized feature of the human microbiome. Genome Biol. 15, 531 (2014).","journal-title":"Genome Biol."},{"key":"952_CR52","doi-asserted-by":"crossref","unstructured":"Galenkamp, H. et al. Cohort Profile Update: The Healthy Life in an Urban Setting (HELIUS) Study. Int J Epidemiol. 54, dyaf071 (2025).","DOI":"10.1093\/ije\/dyaf071"},{"key":"952_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/eurpub\/cku138","volume":"25","author":"M Norredam","year":"2015","unstructured":"Norredam, M. et al. Remigration of migrants with severe disease: myth or reality?\u2014a register-based cohort study. Eur. J. Public Health 25, 84\u201389 (2015).","journal-title":"Eur. J. Public Health"},{"key":"952_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12110-017-9303-1","volume":"28","author":"P Puschmann","year":"2017","unstructured":"Puschmann, P., Donrovich, R. & Matthijs, K. Salmon bias or red herring? Comparing adult mortality risks (Ages 30-90) between natives and internal Migrants: stayers, returnees and movers in Rotterdam, the Netherlands, 1850-1940. Hum. Nat. 28, 481\u2013499 (2017).","journal-title":"Hum. Nat."},{"key":"952_CR55","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012865","volume":"8","author":"H Kim","year":"2019","unstructured":"Kim, H. et al. Plant-based diets are associated with a lower risk of incident cardiovascular disease, cardiovascular disease mortality, and all-cause mortality in a general population of middle-aged adults. J. Am. Heart Assoc. 8, e012865 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"952_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2017-017873","volume":"7","author":"MB Snijder","year":"2017","unstructured":"Snijder, M. B. et al. Cohort profile: the Healthy Life in an Urban Setting (HELIUS) study in Amsterdam, the Netherlands. BMJ Open 7, 1\u201311 (2017).","journal-title":"BMJ Open"},{"key":"952_CR57","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti, K. G. M. M. et al. Harmonizing the metabolic syndrome. Circulation 120, 1640\u20131645 (2009).","journal-title":"Circulation"},{"key":"952_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ejcn.2014.180","volume":"69","author":"MH Beukers","year":"2015","unstructured":"Beukers, M. H. et al. Development of the HELIUS food frequency questionnaires: ethnic-specific questionnaires to assess the diet of a multiethnic population in The Netherlands. Eur. J. Clin. Nutr. 69, 579\u2013584 (2015).","journal-title":"Eur. J. Clin. Nutr."},{"key":"952_CR59","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova, V. W. et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA 326, 1614\u20131621 (2021).","journal-title":"JAMA"},{"key":"952_CR60","doi-asserted-by":"crossref","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42, 2439\u20132454 (2021).","DOI":"10.1093\/eurheartj\/ehab309"},{"key":"952_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12861","author":"R Mobini","year":"2017","unstructured":"Mobini, R. et al. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: a randomized controlled trial. Diab. Obes. Metab. https:\/\/doi.org\/10.1111\/dom.12861 (2017).","journal-title":"Diab. Obes. Metab."},{"key":"952_CR62","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1128\/AEM.01043-13","volume":"79","author":"JJ Kozich","year":"2013","unstructured":"Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79, 5112\u20135120 (2013).","journal-title":"Appl. Environ. Microbiol."},{"key":"952_CR63","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nbt.3820","volume":"35","author":"P Di Tommaso","year":"2017","unstructured":"Di Tommaso, P. et al. Nextflow enables reproducible computational workflows. Nat. Biotechnol. 35, 316\u2013319 (2017).","journal-title":"Nat. Biotechnol."},{"key":"952_CR64","doi-asserted-by":"publisher","first-page":"e2584","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mah\u00e9, F. VSEARCH: a versatile open source tool for metagenomics. PeerJ 4, e2584 (2016).","journal-title":"PeerJ"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00952-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00952-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T07:05:25Z","timestamp":1776668725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-026-00952-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1038\/s41522-026-00952-6","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.N. is on the Scientific Advisory Board of Caelus Pharmaceuticals and Advanced Microbiome Interventions, the Netherlands. However, none of these bear direct relevance to the current manuscript. The other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}